A study of patient-derived tumor samples in the Cancer Genome Atlas database showed that CCN2 expression was higher in head and neck cancers, and high expression of CCN2 and MMP3 was associated with worse prognosis in head and neck cancers54. The gene discussed is CCN2; the disease is head and neck cancer.